Untreated hypertension patients at high risk of open-angle glaucoma

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-05-02 14:30 GMT   |   Update On 2023-05-03 04:54 GMT
Advertisement

Korea: According to a study published in the American Journal of Ophthalmology, researchers have concluded that the risk of open-angle glaucoma increases with the risk of untreated blood pressure.

Hypertension (HTN) is associated with open-angle glaucoma (OAG). The question is whether elevated blood pressure (BP) alone is associated with OAG.

There needs to be more research and data on Whether stage 1 hypertension increases the disease risk, as per the 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP guidelines.

Advertisement

The researchers in the present retrospective, observational cohort study investigated the above background, including 360,330 subjects ≥40 years and not taking antihypertensive drugs or antiglaucoma drugs at the time of examinations.

The categories of Subjects were untreated BP, into normal BP (systolic BP (SBP)<120 and diastolic BP (DBP)<80 mmHg; n=104,304), elevated BP (SBP 120-129 and DBP<80mmHg; n=33,139), stage 1 HTN (SBP 130-139 or DBP 80-89 mmHg; n=122,534) or stage 2 HTN (SBP≥140 or DBP≥90mmHg; n=100,353).

The study summary is :

  • Among the participants, 56.2 % were male, with a mean age of 51.17±8.97 years.
  • The mean follow-up period was 11.76±1.37 years.
  • Twelve thousand eight hundred forty-one subjects had OAG.
  • Multivariable-adjusted HRs for elevated BP, stage 1 HTN and stage 2 HTN with normal BP as the reference were 1.056, 1.101 and 1.114, respectively.

Concluding further, they said OAG risk increases with increases in untreated BP.

They mentioned Stage 1 HTN as a significant risk factor for OAG. The study has addressed the role of screening and monitoring for glaucoma in those diagnosed with hypertension.

Further reading:

Increased risks of open-angle glaucoma in untreated hypertension. https://doi.org/10.1016/j.ajo.2023.03.032


Tags:    
Article Source : American Journal of Ophthalmology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News